June 12, 2019

Brazilian regulatory agency (ANVISA) inaugurates discussion on cannabis for medicinal and scientific purposes

ANVISA’s Board of Directors approved the proposal to open two Public Consultations to regulate:

(i) the cultivation of the cannabis spp. for medical and scientific purposes; and

(ii) a specific procedure for registration and monitoring of medicines based on Cannabis spp., its derivatives, and synthetic analogs.

For further information, click below to access our full newsletter.

Last related news

December 12, 2024

The Brazilian Patent and Trademark Office (BPTO) has announced modifications to the Patent Prosecution Highway (PPH) Program by means of Ordinance 48/2024, … Important Update: New Rules for the Patent Prosecution Highway (PPH) in Brazil

December 6, 2024

Through Ordinance/INPI/PR/N° 46, dated November 27, 2024, the Brazilian National Institute of Industrial Property (INPI) published its new Relationship and Transparency Policy, … Brazilian PTO (INPI) publishes new Relationship and Transparency Policy

December 5, 2024

The Brazilian PTO (BPTO) had already established, through Ordinance/INPI/DIRPA No. 14, of August 29, 2024, general procedural rules regarding the form and … Establishment of procedures for examining patent certificates of addition